GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Current Accrued Expense

Bristol-Myers Squibb Co (LIM:BMY) Current Accrued Expense : $512 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bristol-Myers Squibb Co Current Accrued Expense?

Bristol-Myers Squibb Co's Current Accrued Expense for the quarter that ended in Sep. 2024 was $512 Mil.

Bristol-Myers Squibb Co's quarterly Current Accrued Expense increased from Mar. 2024 ($546 Mil) to Jun. 2024 ($591 Mil) but then declined from Jun. 2024 ($591 Mil) to Sep. 2024 ($512 Mil).

Bristol-Myers Squibb Co's annual Current Accrued Expense declined from Dec. 2021 ($378 Mil) to Dec. 2022 ($321 Mil) but then increased from Dec. 2022 ($321 Mil) to Dec. 2023 ($349 Mil).

Bristol-Myers Squibb Co Current Accrued Expense Historical Data

The historical data trend for Bristol-Myers Squibb Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Current Accrued Expense Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 493.00 434.00 378.00 321.00 349.00

Bristol-Myers Squibb Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 371.00 349.00 546.00 591.00 512.00

Bristol-Myers Squibb Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Bristol-Myers Squibb Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Current Accrued Expense
Comparable Companies
GILD PFE AMGN BIIB OGN AMRN SCLX MIRA MRK ABBV LLY OCSE:NOVO B JNJ XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 TSE:4568
Traded in Other Exchanges
BMYMP.PFD:USA BMY:USA BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina
Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Website
https://www.bms.com
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.